Regulatory T cells control diabetes without compromising acute anti-viral defense.
Regulatory T cells control diabetes without compromising acute anti-viral defense.
复制标题
DOI:
10.1016/j.clim.2014.05.006
复制
发表时间:
2014-08
期刊:
影响因子:
--
通讯作者:
von Herrath M
中科院分区:
文献类型:
--
作者:
Jones CB;Pagni PP;Fousteri G;Sachithanantham S;Dave A;Rodriguez-Calvo T;Miller J;von Herrath M
While previous reports have demonstrated the efficacy of regulatory T cell therapy in the prevention of diabetes, systemic immunocompromise and Treg instability remain key safety concerns. Here we examined the influence of induced Treg (iTreg) cell therapy on anti-viral host defense and autoimmune T cell responses during acute viral infection in a murine model of autoimmune diabetes. Protective transfers of iTregs maintained IL-10 expression, and expanded in vivo and controlled diabetes, despite losing FoxP3 expression. Adoptive transfer of iTregs affected neither the primary anti-viral CD8 T cell response nor viral clearance, although a significant and sustained suppression of CD4 T cell responses was observed. Following acute viral clearance, iTregs transferred early suppressed both CD4 and CD8 T cell responses, which resulted in the reversion of diabetes. These observations indicate that iTregs suppress local autoimmune processes while preserving the immunocompetent host's ability to combat acute viral infection.